AGH 3.94 0.00 Vol 0 AGL 17 0.00 Vol 26117 BAS 1.7 -0.45 Vol 500 BFM 16.5 0.00 Vol 0 BG23B 98.0002 0.00 Vol 0 BPH 7 0.00 Vol 0 DEVON 3.55 0.00 Vol 0 LOM 2.5 0.00 Vol 0 NTB 51.5 0.00 Vol 0 ONE 3 0.00 Vol 0 POLAR 5 0.00 Vol 0 SOM 16 0.00 Vol 0 WHHL 4.06 0.00 Vol 0 WWW 21.5 0.00 Vol 0
Market Closed:
Canon’s Court,
22 Victoria Street,
Hamilton,
HM12,
Bermuda
Listed Since: 2015/08/28
Currency: BMD

Horizon Pharma Investment Limited a company registered in Bermuda under registration number EC50064 and is a wholly-owned subsidiary of Horizon Pharma plc (“the Parent”).

The Issuer’s Parent, Horizon Pharma, is a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring or in-licensing and commercializing differentiated products that address unmet medical needs. Horizon Pharma markets a portfolio of products in arthritis, inflammation and orphan diseases.

The proceeds of the 2.50% senior notes due 15 March 2022 are intended for general corporate purposes.

FINANCIAL AND OTHER INFORMATION

LISTING SPONSOR

TRADING HOURS

08:30-09:00 Price Discovery
09:00-16:30 Continuous Trading

CONTACT DETAILS

TEL: +1 (441) 292 7212
FAX: +1 (441) 292 7619
Email: info@bsx.com

LOCATION

30 Victoria Street
3rd Floor
Hamilton, Bermuda

MAILING ADDRESS

P.O. Box HM 1369
Hamilton HMFX

Disclaimer

 

The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website.